Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
This clinical trial update reports on a pharmacogenomics study in breast cancer patients undergoing adjuvant chemotherapy with doxorubicin/c…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Breast Cancer Risk Biomarkers in Premenopausal Women [Phase 2]
This document reports the results of a Phase 2 clinical trial evaluating breast cancer risk biomarkers in premenopausal women. Results were …
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer [NA]
An update on the experience of a patient treated with trastuzumab (Herceptin) as adjuvant therapy for breast cancer in a completed clinical …
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Choices for Latinas and Clinical Trials [NA]
This entry notes the completion of a UT Health San Antonio–sponsored clinical trial related to breast cancer and Latina participation in tri…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer [Phase 2]
Phase 2 trial comparing DA versus DAC as postoperative adjuvant therapy for early-stage breast cancer has completed, led by Peking Union Med…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis [Phase 2]
Phase 2 study evaluating the efficacy and safety of CBLB612 for neutropenia prophylaxis in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot [Phase 1]
Phase 1 clinical trial assessing the molecular signature of valproic acid in breast cancer with functional imaging has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer [Phase 2]
Phase 2 trial comparing X to placebo as postoperative adjuvant treatment for elderly breast cancer patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating interleukin-12 for metastatic or recurrent breast cancer has completed enrollment. The update summarizes…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer [Phase 3]
Phase 3 trial evaluating zoledronic acid with calcium and vitamin D to prevent bone loss in women undergoing adjuvant chemotherapy for breas…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the safety and preliminary efficacy of γδ T cell therapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Nutrition, Physical Activity, and Cognition in Breast Cancer Survivors
This clinical trial investigated the effects of nutrition and physical activity on cognition in breast cancer survivors and is marked as com…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors [Phase 3]
Phase 3 trial evaluating a combined aerobic and resistance exercise program in breast cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Acellular Dermal Matrix in Breast Reconstruction
This clinical trial update confirms the completion of a study evaluating acellular dermal matrix in breast reconstruction for breast cancer …
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Delayed-Immediate Breast Reconstruction [Phase 2]
Phase 2 results update on delayed-immediate breast reconstruction for breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 study of panobinostat as monotherapy in HER2-negative locally recurrent or metastatic breast cancer completed; results were posted i…
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Delayed-Delayed Breast Reconstruction [NA]
The clinical trial NCT01256528 on delayed-delayed breast reconstruction for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating irinotecan in patients with refractory metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy [Phase 3]
Phase 3 trial evaluating gabapentin with or without antidepressants for hot flashes in women who have had breast cancer or are concerned abo…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Docetaxel in Treating Patients With Solid Tumors [Phase 2]
Docetaxel was studied in a Phase 2 trial across multiple solid tumors and has completed the study.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer [Phase 3]
This Phase 3 trial evaluates whether adding dalteparin to standard therapy improves outcomes in patients with advanced breast, lung, colorec…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer [Phase 3]
A Phase 3 trial assessing whether risedronate can prevent chemotherapy-induced bone loss in premenopausal women treated for primary breast c…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy [Phase 3]
A Phase 3 trial evaluating epoetin alfa for chemotherapy-induced anemia has completed, with an update summarizing trial status across multip…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer [Phase 2]
This document reports on a Phase 2 clinical trial evaluating the combination of gemcitabine and cisplatin in patients with metastatic breast…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
A clinical trial update reports changes in breast density and blood hormone levels in postmenopausal women with breast cancer treated with t…